Armune Investors
- Intellectual Property -
Armune's intellectual property position for autoantibody technologies includes an exclusive license from the University of Michigan to US, PCT, and WO patent applications, and one patent that has been issued, US7,597,890. In addition, Armune is augmenting its IP by filing new patent applications based on internal discoveries.